On October 31, 2019 Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (Nasdaq: EGRX) reported that the Company will release its 2019 third quarter financial results on Tuesday, November 12, 2019, before the market opens (Press release, Eagle Pharmaceuticals, OCT 31, 2019, View Source [SID1234550122]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will host a conference call to discuss the results as follows:
Date
Tuesday, November 12, 2019
Time
8:30 a.m. EST
Toll free (U.S.)
866-342-8591
International
203-518-9713
Webcast (live and replay)
www.eagleus.com, under the "Investor Relations" section
A replay of the conference call will be available for one week after the call’s completion by dialing 800-839-4577 (US) or 402-220-2682 (International) and entering conference call ID EGRXQ319. The webcast will be archived for 30 days at the aforementioned URL.